Ovarian tumours, their characterisation and origins and ovarian screening

References

• Annaiah T, Reynolds S, Lopez C. 2012. Histology and prevalence of ovarian tumours in postmenopausal women: is follow up required in all cases? Journal of Obstetrics and Gynaecology: this issue.
   Google Scholar
• Booth M, Beral V, Smith P. 1989. Risk factors for ovarian cancer: a case–control study. British Journal of Cancer 60:592–598.
   PubMed Web of Science ®Google Scholar
• Crum CP, Drapkin R, Miron A, Ince TA, Muto M, Kindleberger DW . 2007. The distal fallopian tube: a new model for pelvic serous carcinogenesis. Current Opinions in Obstetrics and Gynecology 19:3–9.
   PubMed Web of Science ®Google Scholar
• Deligdisch L, Gil J, Kerner H, Wu HS, Beck D, Gershoni-Baruch R. 1999. Ovarian dysplasia in prophylactic oophorectomy specimens: cytogenetic and morphometric correlations. Cancer 86:1544–1550.
   PubMed Web of Science ®Google Scholar
• DePriest PD, DeSimone CP. 2003. Ultrasound screening for the early detection of ovarian cancer. Journal of Clinical Oncology 21:194s–199s.
   Google Scholar
• dos Santos Silva I, Wark PA, McCormack VA, Mayer D, Overton C, Little V . 2009. Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohort. British Journal of Cancer 100:1824–1831.
   PubMedGoogle Scholar
• Fathalla MF. 1971. Incessant ovulation – a factor in ovarian neoplasia. Lancet ii:163.
   Google Scholar
• Hardiman PJ, Nieto JJ, MacLean AB. 2000. Infertility and ovarian cancer. Gynecologic Oncology 76:1–2.
   PubMedGoogle Scholar
• Klip H, Burger CW, Kenemans P, van Leeuwen FE. 2000. Cancer risk associated with subfertility and ovulation induction: a review. Cancer Causes and Control 11:319–344.
   PubMedGoogle Scholar
• Kobayashi H, Yamada Y, Sado T, Sakata M, Yoshida S, Kawaguchi R . 2008a. A randomized study of screening for ovarian cancer: a multicenter study in Japan. International Journal of Gynecologic Cancer 18:414–420.
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Yamada Y, Sado T, Sakata M, Yoshida S, Kawaguchi R . 2008b. Prevalence of ovarian cancer among women with a CA125 level of 35U/ml or less. Gynecologic and Obstetric Investigations 65:133–138.
   PubMedGoogle Scholar
• McDonald JM, Doran S, DeSimone CP, Ueland FR, DePriest PD, Ware RA . 2010. Predicting risk of malignancy in adnexal masses. Obstetrics and Gynecology 115:687–694.
   PubMed Web of Science ®Google Scholar
• Menon U, Gentry-Maharaj A, Hallett R, Ryan A, Burnell M, Sharma A . 2009. Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK collaborative trial of ovarian cancer screening (UKCTOCS). Lancet Oncology 10:327–340.
   PubMed Web of Science ®Google Scholar
• Mittal KR, Zeleniuch-Jacquotte A, Cooper JL, Demopoulos RI. 1993. Contralateral ovary in unilateral ovarian carcinoma: a search for preneoplastic lesions. International Journal Gynecological Pathology 12:59–63.
   PubMedGoogle Scholar
• Moore RG, Jabre-Raughley M, Brown AK, Robison KM, Miller MC, Allard WJ . 2010. Comparison of a novel marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass. American Journal of Obstetrics and Gynecology 203:228.e1–e6.
   PubMedGoogle Scholar
• Ness RB, Cramer DW, Goodman MT, Kjaer SK, Mallin K, Mosgaard BJ . 2002. Infertility, fertility drugs and ovarian cancer: a pooled analysis of case–control studies. American Journal of Epidemiology 155:217–224.
   PubMed Web of Science ®Google Scholar
• Nieto JJ, Rolfe KJ, MacLean AB, Hardiman P. 1999. Ovarian cancer and infertility: a genetic link? Lancet 354:649.
   PubMed Web of Science ®Google Scholar
• Nieto JJ, Crow J, Sundaresan M, Constantinovici N, Perrett CW, MacLean AB . 2001. Ovarian epithelial dysplasia in relation to ovulation induction and nulliparity. Gynecologic Oncology 82:344–349.
   PubMedGoogle Scholar
• Nnene IO, Nieto JJ, Crow JC, Sundaresan M, MacLean AB, Perrett CW . 2004. Cell cycle and apoptotic proteins in relation to ovarian epithelial morphology. Gynecologic Oncology 92:247–251.
   PubMedGoogle Scholar
• Partridge E, Greenlee RT, Xu J-L, Kreimer AR, Williams C, Riley T . 2009. Results from four rounds of ovarian cancer screening in a randomized trial. Obstetrics and Gynecology 113:775–782.
   PubMed Web of Science ®Google Scholar
• Plaxe SC, Deligdisch L, Dottino PR, Cohen CJ. 1990. Ovarian intraepithelial neoplasia demonstrated in patients with stage I ovarian carcinoma. Gynecologic Oncology 38:367–372.
   PubMedGoogle Scholar
• Rabban JT, Karnezis AN, Zaloudek CJ. 2010. Junctional epithelial zones of the fallopian tube: cancer hotspots? International Journal of Gynecological Pathology 30:1–3.
   Google Scholar
• RCOG. 2011. Green-top Guideline No. 62, November. Management of suspected ovarian masses in premenopausal women. London: Royal College of Obstetricians and Gynaecologists.
   Google Scholar
• Resta L, Russo S, Colucci GA, Prat J. 1993. Morphologic precursors of ovarian epithelial tumors. Obstetrics and Gynecology 82:181–186.
   PubMedGoogle Scholar
• Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG. 1994. Ovarian tumours in a cohort of infertile women. New England Journal of Medicine 331:771–776.
   PubMed Web of Science ®Google Scholar
• Seidman JD, Yemelyanova A, Zaino RJ, Kurman RJ. 2010. The fallopian tube-peritoneal junction: a potential site of carcinogenesis. International Journal of Gynecological Pathology 30:4–11.
   Google Scholar
• van Leeuwen FE, Klip H, Mooij TM, van de Swaluw AM, Lambalk CB, Kortman M . 2011. Risk of borderline and invasive ovarian tumours after ovulation induction for in vitro fertilization in a large Dutch cohort. Human Reproduction 12:3456–3465.
   Google Scholar
• van Nagell JR, DePriest PD, Ueland FR, DeSimone CP, Cooper AL, McDonald JM . 2007. Ovarian cancer screening with annual transvaginal sonography. Cancer 109:1887–1896.
   PubMed Web of Science ®Google Scholar
• Vang R, Shih I-M, Kurman RJ. 2009. Ovarian low-grade and high grade serous carcinoma. Pathogenesis, clinicopathologic and molecular biologic features and diagnostic features, and diagnostic problems. Advances in Anatomic Pathology 16:267–282.
   PubMed Web of Science ®Google Scholar
• Venn A, Watson L, Bruinsma F, Giles G, Healy D. 1999. Risk of cancer after use of fertility drugs with in vitro fertilisation. Lancet 354:1586–1590.
   PubMed Web of Science ®Google Scholar
• Venn A, Watson L, Lumley J, Giles G, King C, Healy D. 1995. Breast and ovarian cancer incidence after infertility and in vitro fertilisation. Lancet 346:995–1000.
   PubMed Web of Science ®Google Scholar
• Whittemore AS, Harris R, Itnrye J, for the Collaborative Ovarian Cancer Group. 1992. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case–control studies. II. Invasive epithelial ovarian cancers in white women. American Journal of Epidemiology 136: 1184–1203.
   PubMed Web of Science ®Google Scholar
• Wong A, MacLean AB, Furrows SJ, Ridgway GL, Hardiman PJ, Perrett CW. 2007. Could epithelial ovarian cancer be associated with chlamydial infection? European Journal of Gynaecologic Oncology 28:117–120.
   PubMedGoogle Scholar